Citadel Advisors
OCEA

Citadel Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Citadel Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,400
Closed -$886 – 15752
2025
Q1 		$886 Buy
16,400
+14,500
+763% +$3.46K ﹤0.01% 14202
2024
Q4 		$1.05K Buy
1,900
+1,300
+217% +$1.02K ﹤0.01% 14231
2024
Q3 		$588 Buy
600
+400
+200% +$428 ﹤0.01% 13991
2024
Q2 		$244 Sell
200
-3,800
-95% -$6.48K ﹤0.01% 14054
2024
Q1 		$15.1K Buy
+4,000
New +$7.52K ﹤0.01% 13201

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Citadel Advisors's OCEA Position: Q2 2025 in Review

Citadel Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 473,098 shares — an estimated $25.5K sold.

Citadel Advisors first reported a position in OCEA in Q1 2024 and held it in 4 quarters. The position peaked at $32.3K in Q3 2024. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Citadel Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 473,098 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $25.5K.
  • Citadel Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • Citadel Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $32.3K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.